Medifast (NYSE:MED) CEO Buys $178,724.58 in Stock

Medifast Inc (NYSE:MED) CEO Daniel Chard acquired 17,678 shares of the firm’s stock in a transaction that occurred on Friday, March 20th. The stock was acquired at an average price of $10.11 per share, with a total value of $178,724.58. Following the completion of the transaction, the chief executive officer directly owned 17,678 shares in the company, valued at $178,724.58. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Medifast Stock Performance

Shares of MED stock opened at $9.71 on Friday. The company has a market capitalization of $106.69 million, a P/E ratio of -5.68 and a beta of 0.52. The company’s 50 day moving average price is $10.72 and its two-hundred day moving average price is $11.68. Medifast Inc has a 52 week low of $9.22 and a 52 week high of $15.46.

Medifast (NYSE:MED) last released its quarterly earnings results on Tuesday, February 17th. The specialty retailer reported ($0.55) earnings per share for the quarter, beating the consensus estimate of ($0.76) by $0.21. Medifast had a negative net margin of 4.84% and a negative return on equity of 4.27%. The company had revenue of $75.10 million during the quarter, compared to analysts’ expectations of $71.40 million. Medifast has set its FY 2026 guidance at -2.750–1.55 EPS and its Q1 2026 guidance at -0.700–0.15 EPS. Analysts forecast that Medifast Inc will post 0.51 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Stephens reduced their target price on shares of Medifast from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, February 19th. Wall Street Zen raised Medifast from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Medifast in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $12.00.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Divisadero Street Capital Management LP acquired a new stake in shares of Medifast in the 2nd quarter valued at approximately $1,122,000. PNC Financial Services Group Inc. grew its stake in shares of Medifast by 261.8% in the second quarter. PNC Financial Services Group Inc. now owns 2,001 shares of the specialty retailer’s stock valued at $28,000 after buying an additional 1,448 shares in the last quarter. Prescott Group Capital Management L.L.C. increased its holdings in Medifast by 39.1% during the fourth quarter. Prescott Group Capital Management L.L.C. now owns 111,244 shares of the specialty retailer’s stock worth $1,188,000 after buying an additional 31,275 shares during the last quarter. Peapod Lane Capital LLC increased its holdings in Medifast by 15.2% during the fourth quarter. Peapod Lane Capital LLC now owns 101,567 shares of the specialty retailer’s stock worth $1,085,000 after buying an additional 13,403 shares during the last quarter. Finally, Savant Capital LLC bought a new stake in Medifast during the third quarter worth $194,000. 95.51% of the stock is owned by institutional investors and hedge funds.

About Medifast

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.